Galli L - Search Results

1

Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data From the PRESTIGIO Registry.

Galli L, Parisi MR, Poli A, Menozzi M, Fiscon M, Garlassi E, Francisci D, Di Biagio A, Sterrantino G, Fornabaio C, Degli Antoni A, Angarano G, Fusco FM, D'Arminio Monforte A, Corbelli GM, Santoro MM, Zazzi M, Castagna A; PRESTIGIO Study Group. Galli L, et al. Open Forum Infect Dis. 2020 Sep 26;7(11):ofaa456. doi: 10.1093/ofid/ofaa456. eCollection 2020 Nov. Open Forum Infect Dis. 2020. PMID: 33241063 Free PMC article.

2

Diagnostic accuracy and predictive value of 201T1 SPET for the differential diagnosis of cerebral lesions in AIDS patients.

D'Amico A, Messa C, Castagna A, Zito F, Galli L, Pepe G, Lazzarin A, Lucignani G, Fazio F. D'Amico A, et al. Among authors: galli l. Nucl Med Commun. 1997 Aug;18(8):741-50. doi: 10.1097/00006231-199708000-00008. Nucl Med Commun. 1997. PMID: 9293505

3

Pretreatment of chronic active hepatitis C in patients coinfected with HIV and hepatitis C virus reduces the hepatotoxicity associated with subsequent antiretroviral therapy.

Uberti-Foppa C, De Bona A, Morsica G, Galli L, Gallotta G, Boeri E, Lazzarin A. Uberti-Foppa C, et al. Among authors: galli l. J Acquir Immune Defic Syndr. 2003 Jun 1;33(2):146-52. doi: 10.1097/00126334-200306010-00005. J Acquir Immune Defic Syndr. 2003. PMID: 12794546 Clinical Trial.

4

Predictors of sustained response to therapy resumption after treatment interruption in HIV-infected patients failing antiretroviral therapy.

Gianotti N, Soria A, Galli L, Castagna A, Cernuschi M, Hasson H, Lazzarin A. Gianotti N, et al. Among authors: galli l. J Med Virol. 2004 Feb;72(2):181-6. doi: 10.1002/jmv.10580. J Med Virol. 2004. PMID: 14695657

5

Selected pool of peptides from ESAT-6 and CFP-10 proteins for detection of Mycobacterium tuberculosis infection.

Scarpellini P, Tasca S, Galli L, Beretta A, Lazzarin A, Fortis C. Scarpellini P, et al. Among authors: galli l. J Clin Microbiol. 2004 Aug;42(8):3469-74. doi: 10.1128/JCM.42.8.3469-3474.2004. J Clin Microbiol. 2004. PMID: 15297485 Free PMC article.

6

The NIQ of lopinavir is predictive of a 48-week virological response in highly treatment-experienced HIV-1-infected subjects treated with a lopinavir/ritonavir-containing regimen.

Castagna A, Gianotti N, Galli L, Danise A, Hasson H, Boeri E, Hoetelmans R, Nauwelaers D, Lazzarin A. Castagna A, et al. Among authors: galli l. Antivir Ther. 2004 Aug;9(4):537-43. Antivir Ther. 2004. PMID: 15456085 Clinical Trial.

7

Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients.

Seminari E, Castagna A, Soldarini A, Galli L, Fusetti G, Dorigatti F, Hasson H, Danise A, Guffanti M, Lazzarin A, Rubinacci A. Seminari E, et al. Among authors: galli l. HIV Med. 2005 May;6(3):145-50. doi: 10.1111/j.1468-1293.2005.00278.x. HIV Med. 2005. PMID: 15876279 Free article.

8

Higher plasma lopinavir concentrations are associated with a moderate rise in cholestasis markers in HIV-infected patients.

Seminari E, Gentilini G, Galli L, Hasson H, Danise A, Carini E, Dorigatti F, Soldarini A, Lazzarin A, Castagna A. Seminari E, et al. Among authors: galli l. J Antimicrob Chemother. 2005 Oct;56(4):790-2. doi: 10.1093/jac/dki314. Epub 2005 Sep 5. J Antimicrob Chemother. 2005. PMID: 16143711

9

Liver fibrosis in HIV-positive patients with hepatitis C virus: role of persistently normal alanine aminotransferase levels.

Uberti-Foppa C, De Bona A, Galli L, Sitia G, Gallotta G, Sagnelli C, Paties C, Lazzarin A. Uberti-Foppa C, et al. Among authors: galli l. J Acquir Immune Defic Syndr. 2006 Jan 1;41(1):63-7. doi: 10.1097/01.qai.0000192001.15777.15. J Acquir Immune Defic Syndr. 2006. PMID: 16340475

10

In vivo dynamics of the K103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in Human Immunodeficiency Virus-infected patients.

Gianotti N, Galli L, Boeri E, Maillard M, Serra G, Ratti D, Gallotta G, Vacchini D, Tremolada Y, Lazzarin A, Clementi M, Castagna A. Gianotti N, et al. Among authors: galli l. New Microbiol. 2005 Oct;28(4):319-26. New Microbiol. 2005. PMID: 16386016

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,153 results

Search Page